Bone Marrow TransplantationTransplantation, HomologousGraft vs Host DiseaseWhole-Body IrradiationBusulfanAnemia, AplasticLeukemiaGraft vs Host ReactionHistocompatibility TestingMethotrexateCyclophosphamideBone MarrowTransplantation, AutologousCytomegalovirus InfectionsHematopoietic Stem Cell TransplantationRecurrenceBone Marrow CellsTransplantation ConditioningLiver TransplantationGraft SurvivalHistocompatibilityTransplantation ChimeraTissue DonorsFollow-Up StudiesGraft RejectionKidney TransplantationHematologic NeoplasmsImmunosuppressionLymphocyte DepletionImmunosuppressive AgentsTransplantation, IsogeneicStem Cell TransplantationTreatment OutcomeLeukemia, Myelogenous, Chronic, BCR-ABL PositiveNuclear FamilyHeart TransplantationCombined Modality TherapyLeukemia, Myeloid, AcuteHematopoiesisT-LymphocytesCyclosporineAcute DiseaseTransplantation ImmunologySurvival AnalysisHLA AntigensTime FactorsLung TransplantationBone Marrow PurgingRetrospective StudiesHematopoietic Stem CellsCyclosporinsRemission InductionInfectionRadiation ChimeraMice, Inbred C57BLOrgan TransplantationCystitisGanciclovirPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseGraft vs Tumor EffectLeukocyte TransfusionIslets of Langerhans TransplantationLife TablesBone Marrow DiseasesGraft vs Leukemia EffectCell TransplantationLeukemia, MyeloidSkin TransplantationPancreas TransplantationMyelodysplastic SyndromesTransplantationPeripheral Blood Stem Cell TransplantationCord Blood Stem Cell TransplantationLymphoma, Non-HodgkinSurvival RateChimeraTransplantation ToleranceHematologic DiseasesActuarial AnalysisMice, Inbred BALB CAntilymphocyte SerumBone Marrow ExaminationSpleenSevere Combined ImmunodeficiencyLiving DonorsIsoantigensAntineoplastic Combined Chemotherapy ProtocolsColony-Forming Units AssayLymphocyte Culture Test, MixedGranulocyte Colony-Stimulating FactorTransplantation, HeterotopicChimerismLymphocyte TransfusionCytarabineMultiple MyelomaMelphalanLymphomaLeukocyte CountCarmustine